新型冠状病毒肺炎患者血清中卟啉浓度异常。 - Suppr

Abnormal concentration of porphyrins in serum from COVID-19 patients.

作者信息

San Juan Itxaso, Bruzzone Chiara, Bizkarguenaga Maider, Bernardo-Seisdedos Ganeko, Laín Ana, Gil-Redondo Rubén, Diercks Tammo, Gil-Martínez Jon, Urquiza Pedro, Arana Eunate, Seco Marisa, García de Vicuña Aitor, Embade Nieves, Mato José M, Millet Oscar

机构信息

Precision Medicine and Metabolism Laboratory, CIC bioGUNE, Basque Research and Technology Alliance, Derio, Spain.

ATLAS Molecular Pharma S. L, Derio, Spain.

出版信息

Br J Haematol. 2020 Sep;190(5):e265-e267. doi: 10.1111/bjh.17060. Epub 2020 Aug 29.

DOI:10.1111/bjh.17060

PMID:32745239

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7436216/

Abstract

摘要

相似文献

Abnormal concentration of porphyrins in serum from COVID-19 patients.

Br J Haematol. 2020 Sep;190(5):e265-e267. doi: 10.1111/bjh.17060. Epub 2020 Aug 29.

Changes in blood coagulation in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis.

Br J Haematol. 2020 Jun;189(6):1050-1052. doi: 10.1111/bjh.16725. Epub 2020 May 14.

Management of COVID-19-related paediatric blood samples in a clinical haematology laboratory.

Br J Haematol. 2020 Jun;189(5):848-851. doi: 10.1111/bjh.16721. Epub 2020 May 9.

The association between COVID-19 and asthma: A systematic review and meta-analysis.

Clin Exp Allergy. 2020 Nov;50(11):1274-1277. doi: 10.1111/cea.13733. Epub 2020 Sep 24.

Thrombolysis restores perfusion in COVID-19 hypoxia.

Br J Haematol. 2020 Sep;190(5):e270-e274. doi: 10.1111/bjh.17050. Epub 2020 Aug 17.

Type I IFN immunoprofiling in COVID-19 patients.

J Allergy Clin Immunol. 2020 Jul;146(1):206-208.e2. doi: 10.1016/j.jaci.2020.04.029. Epub 2020 Apr 29.

The association of low serum albumin level with severe COVID-19: a systematic review and meta-analysis.

Crit Care. 2020 May 26;24(1):255. doi: 10.1186/s13054-020-02995-3.

Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19.

N Engl J Med. 2020 Jul 16;383(3):288-290. doi: 10.1056/NEJMc2013656. Epub 2020 May 5.

Kinetics of viral load and antibody response in relation to COVID-19 severity.

J Clin Invest. 2020 Oct 1;130(10):5235-5244. doi: 10.1172/JCI138759.

SARS-CoV-2 Cysteine-like Protease Antibodies Can Be Detected in Serum and Saliva of COVID-19-Seropositive Individuals.

J Immunol. 2020 Dec 1;205(11):3130-3140. doi: 10.4049/jimmunol.2000842. Epub 2020 Nov 4.

引用本文的文献

Plasma metabolomics signatures predict COVID-19 patient outcome at ICU admission comparable to clinical scores.

Sci Rep. 2025 May 3;15(1):15498. doi: 10.1038/s41598-025-00373-z.

Unmasked acute intermittent porphyria in a patient with COVID-19-associated posterior reversible encephalopathy syndrome.

BMC Neurol. 2025 Apr 4;25(1):139. doi: 10.1186/s12883-025-04159-8.

Crosstalk between ROS-inflammatory gene expression axis in the progression of lung disorders.

Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan;398(1):417-448. doi: 10.1007/s00210-024-03392-1. Epub 2024 Aug 28.

Re: Porphyria Cutanea Tarda in a Patient with Myelofibrosis.

Sultan Qaboos Univ Med J. 2023 Aug;23(3):425-426. doi: 10.18295/squmj.8.2023.047. Epub 2023 Aug 28.

Acute Intermittent Porphyria Attack Triggered by COVID-19 Infection.

Cureus. 2023 Apr 10;15(4):e37412. doi: 10.7759/cureus.37412. eCollection 2023 Apr.

Metabolomics as a powerful tool for diagnostic, pronostic and drug intervention analysis in COVID-19.

Front Mol Biosci. 2023 Feb 15;10:1111482. doi: 10.3389/fmolb.2023.1111482. eCollection 2023.

An NMR-Based Model to Investigate the Metabolic Phenoreversion of COVID-19 Patients throughout a Longitudinal Study.

Metabolites. 2022 Dec 1;12(12):1206. doi: 10.3390/metabo12121206.

Prospective Metabolomic Studies in Precision Medicine: The AKRIBEA Project.

Handb Exp Pharmacol. 2023;277:275-297. doi: 10.1007/164_2022_610.

Association of COVID-19 with hepatic metabolic dysfunction.

World J Virol. 2022 Sep 25;11(5):237-251. doi: 10.5501/wjv.v11.i5.237.

Host and viral proteins involved in SARS-CoV-2 infection differentially bind heme.

Protein Sci. 2022 Nov;31(11):e4451. doi: 10.1002/pro.4451.

本文引用的文献

H NMR-Based Urine Metabolomics Reveals Signs of Enhanced Carbon and Nitrogen Recycling in Prostate Cancer.

J Proteome Res. 2020 Jun 5;19(6):2419-2428. doi: 10.1021/acs.jproteome.0c00091. Epub 2020 May 18.

Incidence of thrombotic complications in critically ill ICU patients with COVID-19.

Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.

Hematological findings and complications of COVID-19.

Am J Hematol. 2020 Jul;95(7):834-847. doi: 10.1002/ajh.25829. Epub 2020 May 23.

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.

Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.

Feasibility of cellular bioenergetics as a biomarker in porphyria patients.

Mol Genet Metab Rep. 2019 Jan 29;19:100451. doi: 10.1016/j.ymgmr.2019.100451. eCollection 2019 Jun.

Repurposing ciclopirox as a pharmacological chaperone in a model of congenital erythropoietic porphyria.

Sci Transl Med. 2018 Sep 19;10(459). doi: 10.1126/scitranslmed.aat7467.

Characterization of iron metabolism and erythropoiesis in erythrocyte membrane defects and thalassemia traits.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Jun;160(2):231-7. doi: 10.5507/bp.2015.054. Epub 2015 Oct 27.

Modulation of red blood cell population dynamics is a fundamental homeostatic response to disease.

Am J Hematol. 2015 May;90(5):422-8. doi: 10.1002/ajh.23982. Epub 2015 Apr 2.

Therapeutic potential of proteasome inhibitors in congenital erythropoietic porphyria.

Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):18238-43. doi: 10.1073/pnas.1314177110. Epub 2013 Oct 21.

The porphyrias: advances in diagnosis and treatment.

Blood. 2012 Nov 29;120(23):4496-504. doi: 10.1182/blood-2012-05-423186. Epub 2012 Jul 12.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Abnormal concentration of porphyrins in serum from COVID-19 patients.

Br J Haematol. 2020 Sep;190(5):e265-e267. doi: 10.1111/bjh.17060. Epub 2020 Aug 29.

Changes in blood coagulation in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis.

Br J Haematol. 2020 Jun;189(6):1050-1052. doi: 10.1111/bjh.16725. Epub 2020 May 14.

Management of COVID-19-related paediatric blood samples in a clinical haematology laboratory.

Br J Haematol. 2020 Jun;189(5):848-851. doi: 10.1111/bjh.16721. Epub 2020 May 9.

The association between COVID-19 and asthma: A systematic review and meta-analysis.

Clin Exp Allergy. 2020 Nov;50(11):1274-1277. doi: 10.1111/cea.13733. Epub 2020 Sep 24.

Thrombolysis restores perfusion in COVID-19 hypoxia.

Br J Haematol. 2020 Sep;190(5):e270-e274. doi: 10.1111/bjh.17050. Epub 2020 Aug 17.

Type I IFN immunoprofiling in COVID-19 patients.

J Allergy Clin Immunol. 2020 Jul;146(1):206-208.e2. doi: 10.1016/j.jaci.2020.04.029. Epub 2020 Apr 29.

The association of low serum albumin level with severe COVID-19: a systematic review and meta-analysis.

Crit Care. 2020 May 26;24(1):255. doi: 10.1186/s13054-020-02995-3.

Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19.

N Engl J Med. 2020 Jul 16;383(3):288-290. doi: 10.1056/NEJMc2013656. Epub 2020 May 5.

Kinetics of viral load and antibody response in relation to COVID-19 severity.

J Clin Invest. 2020 Oct 1;130(10):5235-5244. doi: 10.1172/JCI138759.

SARS-CoV-2 Cysteine-like Protease Antibodies Can Be Detected in Serum and Saliva of COVID-19-Seropositive Individuals.

J Immunol. 2020 Dec 1;205(11):3130-3140. doi: 10.4049/jimmunol.2000842. Epub 2020 Nov 4.

引用本文的文献

Plasma metabolomics signatures predict COVID-19 patient outcome at ICU admission comparable to clinical scores.

Sci Rep. 2025 May 3;15(1):15498. doi: 10.1038/s41598-025-00373-z.

Unmasked acute intermittent porphyria in a patient with COVID-19-associated posterior reversible encephalopathy syndrome.

BMC Neurol. 2025 Apr 4;25(1):139. doi: 10.1186/s12883-025-04159-8.

Crosstalk between ROS-inflammatory gene expression axis in the progression of lung disorders.

Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan;398(1):417-448. doi: 10.1007/s00210-024-03392-1. Epub 2024 Aug 28.

Re: Porphyria Cutanea Tarda in a Patient with Myelofibrosis.

Sultan Qaboos Univ Med J. 2023 Aug;23(3):425-426. doi: 10.18295/squmj.8.2023.047. Epub 2023 Aug 28.

Acute Intermittent Porphyria Attack Triggered by COVID-19 Infection.

Cureus. 2023 Apr 10;15(4):e37412. doi: 10.7759/cureus.37412. eCollection 2023 Apr.

Metabolomics as a powerful tool for diagnostic, pronostic and drug intervention analysis in COVID-19.

Front Mol Biosci. 2023 Feb 15;10:1111482. doi: 10.3389/fmolb.2023.1111482. eCollection 2023.

An NMR-Based Model to Investigate the Metabolic Phenoreversion of COVID-19 Patients throughout a Longitudinal Study.

Metabolites. 2022 Dec 1;12(12):1206. doi: 10.3390/metabo12121206.

Prospective Metabolomic Studies in Precision Medicine: The AKRIBEA Project.

Handb Exp Pharmacol. 2023;277:275-297. doi: 10.1007/164_2022_610.

Association of COVID-19 with hepatic metabolic dysfunction.

World J Virol. 2022 Sep 25;11(5):237-251. doi: 10.5501/wjv.v11.i5.237.

Host and viral proteins involved in SARS-CoV-2 infection differentially bind heme.

Protein Sci. 2022 Nov;31(11):e4451. doi: 10.1002/pro.4451.

本文引用的文献

H NMR-Based Urine Metabolomics Reveals Signs of Enhanced Carbon and Nitrogen Recycling in Prostate Cancer.

J Proteome Res. 2020 Jun 5;19(6):2419-2428. doi: 10.1021/acs.jproteome.0c00091. Epub 2020 May 18.

Incidence of thrombotic complications in critically ill ICU patients with COVID-19.

Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.

Hematological findings and complications of COVID-19.

Am J Hematol. 2020 Jul;95(7):834-847. doi: 10.1002/ajh.25829. Epub 2020 May 23.

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.

Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.

Feasibility of cellular bioenergetics as a biomarker in porphyria patients.

Mol Genet Metab Rep. 2019 Jan 29;19:100451. doi: 10.1016/j.ymgmr.2019.100451. eCollection 2019 Jun.

Repurposing ciclopirox as a pharmacological chaperone in a model of congenital erythropoietic porphyria.

Sci Transl Med. 2018 Sep 19;10(459). doi: 10.1126/scitranslmed.aat7467.

Characterization of iron metabolism and erythropoiesis in erythrocyte membrane defects and thalassemia traits.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Jun;160(2):231-7. doi: 10.5507/bp.2015.054. Epub 2015 Oct 27.

Modulation of red blood cell population dynamics is a fundamental homeostatic response to disease.

Am J Hematol. 2015 May;90(5):422-8. doi: 10.1002/ajh.23982. Epub 2015 Apr 2.

Therapeutic potential of proteasome inhibitors in congenital erythropoietic porphyria.

Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):18238-43. doi: 10.1073/pnas.1314177110. Epub 2013 Oct 21.

The porphyrias: advances in diagnosis and treatment.

Blood. 2012 Nov 29;120(23):4496-504. doi: 10.1182/blood-2012-05-423186. Epub 2012 Jul 12.

Abnormal concentration of porphyrins in serum from COVID-19 patients.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献